EUVIMEDEUVIMED entdecken
EditorialOpen Access

The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis

Fatma Jendoubi iD

Journal of the European Academy of Dermatology and Venereology · 2026-09 · 40 (9) · 1443-1444

DOI: 10.1111/jdv.70593 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 25.08.2026. Verfasst von Fatma Jendoubi. Beteiligte Einrichtung: Dermatology Private Practice, Toulouse, France. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Dermatology Private Practice, Toulouse, France.

ORCID-Profile: Fatma Jendoubi

Zitieren

APA

Jendoubi, F. (2026). The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis. Journal of the European Academy of Dermatology and Venereology, 40(9), 1443-1444. https://doi.org/10.1111/jdv.70593

Vancouver

Jendoubi F. The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis. Journal of the European Academy of Dermatology and Venereology. 2026;40(9):1443-1444. doi:10.1111/jdv.70593

BibTeX
@article{Jendoubi2026,
  author = {Jendoubi, Fatma},
  title = {The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {9},
  pages = {1443--1444},
  doi = {10.1111/jdv.70593}
}
Kostenlos starten →